Aventis Divests Entire Clariant Stake
Advertisement
Aventis announced that it has divested its entire 11.85% holding in the Swiss chemical company Clariant as part of its strategy to focus on pharmaceuticals. The sale was made to selected institutional investors at a price of CHF 19.25 per share.
Most read news
Organizations
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Sachtleben annouces a price increase on all TiO2 products
APPLES consortium to develop improved in-line liquid monitoring technologies for the manufacture of high-value products

Mysterious mechanism of graphene oxide formation explained - Comprehensive view on the driving forces of the complex processes occurring during the transformation of graphite into graphene oxide
DuPont and Applied Materials Collaborate to Boost Solar Cell Efficiency

Physicists discover material for a more efficient energy storage

The Fastest One Wins - Enantioselective synthesis of indole derivatives
Defects in atomically thin semiconductor emit single photons - Researchers create optically active quantum dots in 2-D semiconductor for the first time; may have applications for integrated photonics
A micro-supercapacitor with unmatched energy storage performance

IU physicist leads discovery of new particle: '4-flavored' tetraquark
